1. Home
  2. AUUD vs DCOY Comparison

AUUD vs DCOY Comparison

Compare AUUD & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Auddia Inc.

AUUD

Auddia Inc.

HOLD

Current Price

$1.90

Market Cap

2.6M

Sector

Technology

ML Signal

HOLD

DCOY

Decoy Therapeutics Inc. Common Stock

N/A

Current Price

$5.27

Market Cap

3.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AUUD
DCOY
Founded
2012
N/A
Country
United States
United States
Employees
5
11
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6M
3.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AUUD
DCOY
Price
$1.90
$5.27
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$30.00
AVG Volume (30 Days)
2.0M
14.5K
Earning Date
05-07-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.51
$0.53
52 Week High
$10.10
$9.09

Technical Indicators

Market Signals
Indicator
AUUD
DCOY
Relative Strength Index (RSI) 40.71 45.25
Support Level $1.04 $5.40
Resistance Level $2.69 $6.70
Average True Range (ATR) 0.81 0.46
MACD -0.22 -0.19
Stochastic Oscillator 1.96 15.00

Price Performance

Historical Comparison
AUUD
DCOY

About AUUD Auddia Inc.

Auddia Inc is a United States-based company. It operates through its proprietary AI platform for audio and is reinventing not only how consumers engage with AM/FM radio, podcasts, and other audio content but also how artists and labels promote their music and gain access to mainstream radio audiences. The group Discovr Radio is the first music-promotion platform to deliver artists guaranteed exposure to radio listeners. Its flagship audio superapp, called faidr, delivers multiple industry firsts, including: Ad-free listening on any AM/FM radio station, Content skipping across any AM/FM station, One-touch skipping of entire podcast ad breaks, and Integrated artist discovery experiences.

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Share on Social Networks: